Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04274738
Title A Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors X4 Pharmaceuticals
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Colorado Blood Cancer Institute Denver Colorado 80215 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02114 United States Details
Mass General Hospital Cancer Center Boston Massachusetts 02114 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Athens Athens 11528 Greece Details
*Shaded cells indicate that there was no data available from for the field